<?xml version="1.0" encoding="UTF-8"?>
<p id="par0035">Complete blood count, coagulation profile, and serum biochemical tests are routinely performed for COVID-19 patients [
 <xref rid="bib0060" ref-type="bibr">12</xref>]. Lymphocytopenia is a common finding and the percentage of lymphocytes (LYM%) has been suggested as a predictive parameter during disease course. Patients with LYM% &lt; 20 % on day 10–12 after symptom onset tend to have worse outcomes with higher mortality among those with LYM &lt; 5 % [
 <xref rid="bib0065" ref-type="bibr">13</xref>]. A preliminary study proposed a neutrophil-to-lymphocyte ratio (NLR) of ≥ 3.13 as a predictor of severe disease specially in patients above 50 years old, and the authors recommended that these patients should be admitted early to intensive care units (ICU) [
 <xref rid="bib0070" ref-type="bibr">14</xref>].
</p>
